Your browser doesn't support javascript.
loading
Young infants with symptomatic tetralogy of Fallot: Shunt or primary repair?
Ye, Xin Tao; Henmi, Soichiro; Buratto, Edward; Haverty, Mitchell C; Yerebakan, Can; Fricke, Tyson; Brizard, Christian P; d'Udekem, Yves; Konstantinov, Igor E.
Afiliação
  • Ye XT; Department of Cardiac Surgery, Royal Children's Hospital, Melbourne, Victoria, Australia.
  • Henmi S; Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia.
  • Buratto E; Heart Research Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
  • Haverty MC; Division of Cardiac Surgery, Children's National Hospital, Washington, DC.
  • Yerebakan C; Department of Cardiac Surgery, Royal Children's Hospital, Melbourne, Victoria, Australia.
  • Fricke T; Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia.
  • Brizard CP; Heart Research Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
  • d'Udekem Y; Division of Cardiac Surgery, Children's National Hospital, Washington, DC.
  • Konstantinov IE; Division of Cardiac Surgery, Children's National Hospital, Washington, DC.
JTCVS Open ; 19: 241-256, 2024 Jun.
Article em En | MEDLINE | ID: mdl-39015442
ABSTRACT

Objectives:

The optimal treatment strategy for symptomatic young infants with tetralogy of Fallot (TOF) is unclear. We sought to compare the outcomes of staged repair (SR) (shunt palliation followed by second-stage complete repair) versus primary repair (PR) at 2 institutions that have exclusively adopted each strategy.

Methods:

We performed propensity score-matched comparison of 143 infants under 4 months of age who underwent shunt palliation at one institution between 1993 and 2021 with 122 infants who underwent PR between 2004 and 2018 at another institution. The primary outcome was mortality. Secondary outcomes were postoperative complications, durations of perioperative support and hospital stays, and reinterventions. Median follow-up was 8.3 years (interquartile range, 8.1-13.4 years).

Results:

After the initial procedure, hospital mortality (shunt, 2.8% vs PR, 2.5%; P = .86) and 10-year survival (shunt, 95%; 95% confidence interval [CI], 90%-98% vs PR, 90%; 95% CI, 81%-95%; P = .65) were similar. The SR group had a greater risk of early reinterventions but similar rates of late reinterventions. Propensity score matching yielded 57 well-balanced pairs. In the matched cohort, the SR group had similar freedom from reintervention (55%; 95% CI, 39%-68% vs 59%; 95% CI, 43%-71%; P = .85) and greater survival (98%; 95% CI, 88%-99.8% vs 85%; 95% CI, 69%-93%; P = .02) at 10 years, as the result of more noncardiac-related mortalities in the PR group.

Conclusions:

In symptomatic young infants with TOF operated at 2 institutions with exclusive treatment protocols, the SR strategy was associated with similar cardiac-related mortality and reinterventions as the PR strategy at medium-term follow-up.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Idioma: En Revista: JTCVS Open Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Idioma: En Revista: JTCVS Open Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Austrália